arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2402.04068cs.LGcs.CL
收藏

检索以解释:可解释药物靶点识别的证据驱动预测

Retrieve to Explain: Evidence-driven Predictions for Explainable Drug Target Identification

BenevolentAI

Ravi Patel, Angus Brayne, Rogier Hintzen, Daniel Jaroslawicz, Georgiana Neculae, Dane Corneil

AI总结:

提出R2E检索模型,基于证据对药物靶点识别问题评分排序,实现可解释预测,性能超越遗传学方法。

摘要:

语言模型通过综合海量研究语料,在推动科学发现方面展现出巨大潜力。许多复杂的科学研究问题存在多个看似合理的答案,每个答案都有强度不一的证据支持。然而,现有语言模型缺乏基于支持证据对答案合理性进行定量且忠实比较的能力。为解决这一问题,我们引入了“检索以解释”(R2E),一种基于检索的模型,它根据从文档语料库中检索到的证据,对研究问题的所有可能答案进行评分和排序。该架构仅以答案的支持证据来表示每个答案,而答案本身被掩蔽。这使得我们能够扩展诸如Shapley值等特征归因方法,在推理时将答案得分透明地归因于支持证据。该架构还允许在不重新训练的情况下纳入新证据,包括将非文本数据模态模板化为自然语言。我们针对药物靶点识别这一具有挑战性的科学发现任务开发了R2E,该任务是一个人在环过程,其中失败代价极高,可解释性至关重要。在预测药物靶点随后是否会在临床试验中被证实有效时,R2E不仅匹配了不可解释的基于文献的模型,还超越了制药行业广泛使用的基于遗传学的靶点识别方法。

英文摘要:

Language models hold incredible promise for enabling scientific discovery by synthesizing massive research corpora. Many complex scientific research questions have multiple plausible answers, each supported by evidence of varying strength. However, existing language models lack the capability to quantitatively and faithfully compare answer plausibility in terms of supporting evidence. To address this, we introduce Retrieve to Explain (R2E), a retrieval-based model that scores and ranks all possible answers to a research question based on evidence retrieved from a document corpus. The architecture represents each answer only in terms of its supporting evidence, with the answer itself masked. This allows us to extend feature attribution methods such as Shapley values, to transparently attribute answer scores to supporting evidence at inference time. The architecture also allows incorporation of new evidence without retraining, including non-textual data modalities templated into natural language. We developed R2E for the challenging scientific discovery task of drug target identification, a human-in-the-loop process where failures are extremely costly and explainability paramount. When predicting whether drug targets will subsequently be confirmed as efficacious in clinical trials, R2E not only matches non-explainable literature-based models but also surpasses a genetics-based target identification approach used throughout the pharmaceutical industry.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑